What is NowRx?
NowRx is dedicated to revolutionizing pharmacy services by emphasizing convenience, speed, and tailored health insights. The company aims to streamline the medication acquisition process, ensuring clients receive their prescriptions accurately and without delay. Beyond dispensing, NowRx actively empowers individuals by providing a comprehensive repository of health information, featuring articles on various conditions, medication guidance, and wellness strategies. This dual focus on efficient service and educational resources positions NowRx as a key player in enhancing patient engagement and health management.
How much funding has NowRx raised?
NowRx has raised a total of $54.9M across 6 funding rounds:
Angel/Seed
$2M
Series A
$7M
Multiple Rounds
$23.4M
Series C
$22.5M
Angel/Seed (2017): $2M, investors not publicly disclosed
Series A (2018): $7M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Corporate Investment (2020): $3M featuring Decathlon Capital Partners LLC
Series B (2020): $20M, investors not publicly disclosed
Series C (2022): $22.5M, investors not publicly disclosed
Key Investors in NowRx
Decathlon Capital Partners LLC
Decathlon Capital Partners LLC is an investor that has participated in NowRx's funding rounds. Their specific investment focus within the healthcare or technology sectors is not detailed.
What's next for NowRx?
The recent major strategic investment signals a pivotal phase for NowRx, likely enabling accelerated expansion of its service offerings and technological infrastructure. With a history of diverse funding, including corporate backing and earlier-stage capital, the company appears poised for significant scaling. This infusion of capital is expected to fuel further innovation in their pharmacy automation and delivery systems, potentially broadening their market reach and enhancing their competitive edge in the digital health landscape. Strategic partnerships and continued development of their health information platform are anticipated as key priorities.
See full NowRx company page
